Research output per year
Research output per year
Personal profile
Research interests
Immunology is one of the most rapidly growing areas in the biomedical research field. Because no single method is ideal for curing all tumors, multiple disciplines and methods are needed to explore improvements in cancer therapy. Based on my previous findings, I will continue to develop new methods for immunotherapy in MM and related tumors using an interdisciplinary approach. My research will be focused on targeting DKK1 or other novel TAAs for cancer immunotherapy. I will explore the potential of using a novel and universally expressed TAA for immunotherapy of myeloma patients, and further investigate peptide, protein, DNA vaccines or antibody, CAR-T cells for immunotherapy in MM or other cancers.
External positions
Assistant Professor of Cancer Biology Research in Medicine, Weill Cornell Medical College
Jul 1 2019 → …
Research Area Keywords
- Cancer
- Immunobiology & Inflammation
- Molecular Medicine
Free-text keywords
- Immunotherapy
Fingerprint
Dive into the research topics where Jianfei Qian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 66 Article
-
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Su, P., Xiao, L., Ye, L., Wang, Z., Xiong, W., Wang, Q., Ma, X., Xian, M., Yang, M., Zu, Y., Pingali, S. R., Qian, J. & Yi, Q., May 7 2022, In: Journal of Hematology and Oncology. 15, 1, p. 55 55.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Correction: Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages
Su, P., Wang, Q., Bi, E., Ma, X., Liu, L., Yang, M., Qian, J. & Yi, Q., Mar 1 2022, In: Cancer research. 82, 5, p. 945 1 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
Xiao, L., Ma, X., Ye, L., Su, P., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J. & Yi, Q., Apr 1 2022, In: Journal of Clinical Investigation. 132, 7, e153247.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
Wang, Q., Lin, Z., Wang, Z., Ye, L., Xian, M., Xiao, L., Su, P., Bi, E., Huang, Y. H., Qian, J., Liu, L., Ma, X., Yang, M., Xiong, W., Zu, Y., Pingali, S. R., Xu, B. & Yi, Q., Jan 6 2022, In: Blood. 139, 1, p. 59-72 14 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Ma, X., Xiao, L., Liu, L., Ye, L., Su, P., Bi, E., Wang, Q., Yang, M., Qian, J. & Yi, Q., May 4 2021, In: Cell Metabolism. 33, 5, p. 1001-1012.e5Research output: Contribution to journal › Article › peer-review
Open Access299 Scopus citations
Prizes
-
-
Applied Study on Basis of Marek’s Disease Herpesvirus
Qian, Jianfei (Recipient), 1992
Prize: National/international honor
-
Study of oncogenic and nononcogenic strains of Marek’s Herpesvirus
Qian, Jianfei (Recipient), 1998
Prize: National/international honor
-
Vivian L. Smith CCIR Award for Outstanding Young Immunologist
Qian, Jianfei (Recipient), 2007
Prize: Prize (including medals and awards)